Alkermes (ALKS) Current Assets (2011 - 2026)
Alkermes (ALKS) reported Current Assets of $1.4 billion for Q1 2026, down 8.14% year-over-year from $1.5 billion in Q1 2025, and down 29.57% quarter-over-quarter from $1.9 billion in Q4 2025.
Alkermes (ALKS) Current Assets (2011 - 2026) Analysis & Trends
Alkermes (ALKS) has 16 years of Current Assets data on file, last reported at $1.4 billion in Q1 2026.
- Current Assets for Q1 2026 came in at $1.4 billion, down 8.14% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.4 billion (down 8.14% YoY), and the FY2025 annual result was $1.9 billion, up 36.3% from the prior year.
- Current Assets declined to $1.4 billion in Q1 2026 per ALKS's latest filing, from $1.9 billion in the prior quarter.
- Over five years, Current Assets peaked at $1.9 billion in Q4 2025 and troughed at $1.0 billion in Q1 2022.
- A 5-year average of $1.4 billion and a median of $1.5 billion in 2023 frame the typical range for Current Assets.
- The sharpest annual moves came in 2023 and 2026: Current Assets soared 39.0% in 2023, then decreased 8.14% in 2026.
- A 5-year view of Current Assets shows it stood at $1.1 billion in 2022, then surged by 31.43% to $1.5 billion in 2023, then declined by 4.72% to $1.4 billion in 2024, then jumped by 36.3% to $1.9 billion in 2025, then slipped by 29.57% to $1.4 billion in 2026.
- Business Quant data shows ALKS's Current Assets at $1.4 billion in Q1 2026, $1.9 billion in Q4 2025, and $1.7 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 13.71 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 6.47 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 2.87 Bn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 2.44 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 3.58 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 1.36 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 942.29 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 1.05 Bn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 333.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.36 Bn |
| Dec 31, 2025 | 1.93 Bn |
| Sep 30, 2025 | 1.74 Bn |
| Jun 30, 2025 | 1.64 Bn |
| Mar 31, 2025 | 1.48 Bn |
| Dec 31, 2024 | 1.42 Bn |
| Sep 30, 2024 | 1.56 Bn |
| Jun 30, 2024 | 1.54 Bn |
| Mar 31, 2024 | 1.47 Bn |
| Dec 31, 2023 | 1.49 Bn |
| Sep 30, 2023 | 1.46 Bn |
| Jun 30, 2023 | 1.40 Bn |
| Mar 31, 2023 | 1.11 Bn |
| Dec 31, 2022 | 1.13 Bn |
| Sep 30, 2022 | 1.05 Bn |
| Jun 30, 2022 | 1.05 Bn |
| Mar 31, 2022 | 1.01 Bn |
| Dec 31, 2021 | 1.06 Bn |
| Sep 30, 2021 | 1.05 Bn |
| Jun 30, 2021 | 1.04 Bn |